Oxidative stress: The effect of erythropoietin and the dialysis membrane

International Journal of Artificial Organs

Volumn 23, Issue 1, 2000, Pages 33-40

  Eiselt, J ^b   Racek, J ^a   Opatrny, K ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b NONE

Author keywords

Anemia; Chronic renal failure; Erythropoietin; Free radicals; Hemodialysis; Oxidative

Indexed keywords

ANTIOXIDANTS; ENZYMES; FREE RADICALS; HEMODIALYZERS; PATIENT MONITORING; PATIENT TREATMENT;

ANEMIA; ANTIOXIDATIVE DEFENSE; CHRONIC RENAL FAILURE; ERYTHROPOIETIN; FREE RADICAL PRODUCTIONS; GLUTATHIONE PEROXIDASE; HAEMODIALYSIS; HEMOGLOBIN LEVELS; HIGH ACTIVITY; OXIDATIVE;

DIALYSIS;

ALUMINUM; CATALASE; CYANOCOBALAMIN; ERYTHROCYTE ENZYME; FERRITIN; FOLIC ACID; FREE RADICAL; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; HYDROGEN PEROXIDE; HYDROXYL GROUP; IRON; IRON SACCHARATE; LIPOPROTEIN; MALONALDEHYDE; NUCLEIC ACID; PARATHYROID HORMONE; POLYSULFONE; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN;

ADULT; AGED; ANEMIA; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG EFFECT; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS; HUMAN; IRON DEFICIENCY; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0034001803     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300106     Document Type: Article

References (38)

1. Loughrey CM, Young IS, Lightbody JH, McMaster D, McNamee PT, Trimble E. Oxidative stress in hemodialysis. QJM 1994; 87: 679-83.
2. Nenov D, Paskalev D, Yankova T, Tchankova P. Lipid peroxidation and vitamin E in red blood cells and plasma in hemodialysis patients under rHuEPO treatment. Int J Artif Organs 1995; 19: 436-9.
3. Shieh SD, Lu KC, Chu P, et al. Effect of erythropoietin on neutrophil chemiluminescence in hemodialyzed patients. ASAIO J 1991; 37: M189-91.
4. Cappelli G, Lucchi L, Bonucchi D, et al. Polymorphonuclear oxygen free radical production and complement activation induced by dialysis membranes as assayed in an experimental model. Blood Purif 1989; 7: 293-300.
5. Dasgupta A, Hussain S, Ahmad S. Increased lipid peroxidation in patients on maintenance hemodialysis. Nephron 1992; 60: 56-9.
6. Schulz T, Schiffl H, Scheithe R, Hrboticky N, Lorenz R. Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis. Am J Kidney Dis 1995; 25: 564-71.
7. Daugirdas JT, Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-13.
8. 4 intoxication and vitamin E deficiency. Biochem Med 1980; 23: 320-11.
9. Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
10. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-5.
11. Niwa Y, Kasama T, Miyachi Y, Kanoh T. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human ageing: cross-sectional and longitudinal studies. Life Sci 1989; 44: 1655-64.
12. Barnett YA, King CM. An investigation of antioxidant status, DNA repair capacity and mutation as a function of age in humans. Mutat Res 1995; 338: 115-28.
13. Schettler V, Wieland E, Verwiebe R, Schuff-Werner P, Scheler F, Oellerich M. Plasma lipids are not oxidized during hemodialysis. Nephron 1994; 67: 42-7.
14. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patient with chronic renal failure. Clin Chem 1995; 41: 1135-8.
15. Zachée P, Ferrant A, Dalemans R, Goossens W, Boogaerts MA, Lins RL. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communication. Nephron 1995; 71: 343-9.
16. Cristol JP, Bosc JY, Badiou S, et al. Erythropoietin and oxidative stress in hemodialysis: beneficial effecs of vitamin E supplementation. Nephrol Dial Transplant 1997; 12: 2312-7.
17. Chen HC, Tsai JC, Tsai JH, Lai YH. Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients. Kidney Int 1997; 52: 1390-4.
18. Cavdar C, Camsari T, Semin I, Gonenc S, Acikgoz O. Lipid peroxidation and antioxidant activity in chronic hemodialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol 1997; 31: 371-5.
19. Sommerburg O, Grune T, Hampl H, Riedel E. Does long-term treatment of renal anaemia with recombinant erythropoietin influence oxidative stress in hemodialysed patients? Nephrol Dial Transplant 1998; 13: 2583-7.
20. Hernandez de Rojas A, Mateo MC. Superoxide dismutase and catalase activities in patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis. Ren Fail 1996; 18: 937-46.
21. Richard MJ, Arnaud J, Jurkovitz C. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure. Nephron 1991; 57: 10-5.
22. Shurtz-Swirski R, Mashiach E, Kristal B, Shkolnik T, Shasha SM. Antioxidant enzymes activity in polymorphonuclear leukocytes in chronic renal failure. Nephron 1995; 71: 176-9.
23. Maher ER, Wickens DG, Griffin JF, Kyle P, Curtis JR, Dormandy TL. Increased free-radicals activity during hemodialysis? Nephrol Dial Transplant 1987; 2: 169-71.
24. Paul JL, Man NK, Moatti N, Raichvarg D. Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis. Nephrologie 1991; 12: 4-7.
25. Fillit H, Elion E, Sullivan J, Sherman R, Zabriskie JB. Thiobarbituric acid reactive material in uremic blood. Nephron 1984; 29: 40-3.
26. Miguel A, Miguel A, Linares M, et al. Evidence of increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron 1988; 25: 64-5.
27. Luciak M, Trznadel K. Free oxygen species metabolism during hamodialysis with different membranes. Nephrol Dial Transplant 1991; 6 (Suppl 3): 66-70.
28. Sevillano G, Rodriguez-Puyol M, Martos R, et al. Cellulose acetate membrane improves some aspects of red blood cell function in haemodialysis patients. Nephrol Dial Transplant 1990; 5: 497-9
29. Biasioli S, Schiavon R, Petrosino L, et al. Free radicals and oxidative stress challenge dialysis patents: effects of two different membranes. ASAIO J 1997; 43: M766-72.
30. Smit JC, Jones JG. Oxygen saturation during hemodialysis. Ren Fail 1993; 15: 239-45.
31. Sies H. Oxidative stress: introductory remarks. In: Sies H, ed. Oxidative stress. London: Academic Press, 1985; 18.
32. Paul JL, Sail ND, Soni T, et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106-9.
33. Eiselt J, Racek J, Holeček V, Opatrný. Glutathione peroxidase activity in membrane plasmapheresis, acetate-free biofiltration and hemodialysis; Int J Artif Organs 1995; 10: 417.
34. Eiselt J, Racek J, Holeček V, Krejčová I, Opatrný K Jr. Antioxidants and malondialdehyde in hemodialysis with cellulosediacetate and polysulfone membrane. Čas Lék čes 1996; 135: 691-4.
35. Biasioli S, Schiavon R, De Fanti E, Cavalcanti G, Giavarina D. The role of erythrocytes in the deperoxidative processes in people on hemodialysis. ASAIO J 1996; 43: M890-4.
36. Otting U, Hellmann C, Popov I, Lewin G. Equivalence values of the antioxidative capacity in serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation. Z Urol Nephrol 1990; 83: 189-96.
37. Nagase S, Aoyagi K, Hirayama A, et al. Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance. J Am Soc Nephrol 1997; 8: 1157-63.
38. Schmidtmann S, Popov I, Precht K, von Baehr R. Changes in anti-oxidative homeostasis in hemodialysis patients. Z Urol Nephrol 1989; 82: 77-80.